Rapid immunochromatographic assay for qualitative detection of cardiac biomarkers. Point-of-care diagnostic test for cardiovascular event assessment.
Manufactured by
InTec PRODUCTS, INC.
China
Incorporated in 1989, InTec PRODUCTS INC is a world leader IVD manufacturer in infectious disease diagnosis. InTec is a TOP 3 manufacturer having World Health Organization pre-qualifications for HIV and HCV rapid tests in the world, after OraSure Technologies Inc (USA-Thailand) in 2016 and Standard Diagnostics Inc.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Hangzhou Frenovo Biotech Co., Ltd
China · 2 relevant products
ChangChun WanCheng Bio-Electron Co., Ltd.
China · 1 relevant product
HANGZHOU LAIHE BIOTECH CO.,LTD
China · 3 relevant products
83 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →14 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
3 of 113 closest product alternatives
Hangzhou Frenovo Biotech Co., Ltd · China
A rapid diagnostic test for detecting cardiac markers to assess heart disease and cardiac events. This test provides quick results for emergency cardiac screening.
ChangChun WanCheng Bio-Electron Co., Ltd. · China
Rapid immunoassay test for detection of cardiac biomarkers indicating myocardial injury. Supports acute coronary syndrome diagnosis and cardiac event assessment.
HANGZHOU LAIHE BIOTECH CO.,LTD · China
High-sensitivity fluorescence immunoassay panels for cTnI, NT-proBNP, D-Dimer, CK-MB, and Myoglobin designed for point-of-care use in chest pain units, emergency departments, and remote healthcare settings. Provides quantitative limit ≤ 0.1 ng/mL for critical decision making with results in 8–15 minutes from whole blood. Reader-compatible for quantitative reporting and clinically validated against central laboratory methods.
110 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products